General Dynamics Corp <GD.N>: Morgan Stanley Raises Target Price to $465 From $435
GD•Related News
Mycelx Technologies Corp On Track To Meet FY2026 Rev Expectations Of $11 Mln
MYX•
McDonald's India operator Westlife profit halves as costs weigh
MCD•
Biogen <BIIB.O>: JP Morgan raises target price to $210 from $185
BIIB•
Corcept Therapeutics Inc <CORT.O>: Canaccord Genuity Raises Target Price to $161 From $150
CORT•
Boston Scientific Corp <BSX.N>: BTIG cuts target price to $60 from $65
BSX•